Corix Bioscience (Corix Bioscience) EV-to-Revenue : (As of Jun. 17, 2024)

Corix Bioscience EV-to-Revenue Chart

Corix Bioscience Quarterly Data
	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
EV-to-Revenue	Get a 7-Day Free Trial															59.99	97.91	-	-	-

Competitive Comparison of Corix Bioscience's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Corix Bioscience's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Corix Bioscience's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Corix Bioscience's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Corix Bioscience's EV-to-Revenue falls into.

Corix Bioscience EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Corix Bioscience's EV-to-Revenue for today is calculated as:

Corix Bioscience's current Enterprise Value is $0.00 Mil.
Corix Bioscience's Revenue for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corix Bioscience  (GREY:CXBS) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Corix Bioscience's PS Ratiofor today is calculated as:

Corix Bioscience's share price for today is $0.0001.
Corix Bioscience's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corix Bioscience EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Corix Bioscience (Corix Bioscience) Business Description